https://en.bioecon.ru/technologies/monoclonal-antibodies/Recent content in Monoclonal-Antibodies on BioeconHugoen-USSat, 11 Jul 2026 14:19:14 +0700https://en.bioecon.ru/technology/biologics/Thu, 18 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/biologics/Biologics — monoclonal antibodies, ADCs, CAR-T and gene therapy — are the largest and fastest-growing drug class, built on a reproducible cell-line platform at 2–10 g/L titers.https://en.bioecon.ru/technology/antibody-drug-conjugates-adcs/Mon, 01 Jan 0001 00:00:00 +0000https://en.bioecon.ru/technology/antibody-drug-conjugates-adcs/Targeted oncology therapies utilizing monoclonal antibodies to deliver highly potent cytotoxic payloads directly to cancer cells, minimizing systemic toxicity.